Robert Hung
About Robert Hung
Robert Hung is a Partner and Co-Founder at The Dedham Group and Pulse Analytics, specializing in life sciences market access and data analytics. He holds degrees in Bioengineering and Biomedical Engineering, as well as Systems Engineering from Cornell University, and has over a decade of experience in oncology and specialty therapeutics.
Work at Pulse Analytics
Robert Hung serves as Partner and Co-Founder at Pulse Analytics, a role he has held since 2014. Based in New York, NY, he focuses on developing web-based decision-support tools and subscription-based data products tailored for pharmaceutical market access. His work supports targeted engagement planning in oncology and other complex specialty disease areas by utilizing customized dashboards and data services.
Education and Expertise
Robert Hung earned a Bachelor of Applied Science (B.A.Sc.) in Bioengineering and Biomedical Engineering from Cornell University. He furthered his education at the same institution, obtaining a Master of Engineering (M.Eng.) in Systems Engineering. His academic background underpins his extensive expertise in oncology and specialty therapeutics, including rare diseases and cell and gene therapies.
Background
Robert Hung has been a key figure in the life sciences sector since co-founding The Dedham Group in 2010, where he also serves as Partner. His experience spans over 14 years in this role, during which he has developed strategic advisory services in life sciences market access and data analytics. His dual roles at both The Dedham Group and Pulse Analytics highlight his commitment to improving patient access and management trends in healthcare.
Achievements
Throughout his career, Robert Hung has contributed to reducing barriers to patient access in healthcare. He provides insights into account-specific prescribing and management trends, which are critical for stakeholders in the pharmaceutical industry. His involvement in developing customized dashboards and data services has enhanced targeted engagement planning in oncology and other complex specialty disease areas.